First Financial Corp Biogen Inc. Transaction History

First Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$187.54 - $223.02 $5,063 - $6,021	-27 Closed	0 $0
Q1 2020 Apr 15, 2020	SELL	$268.85 - $341.04 $1,344 - $1,705	-5 Reduced 15.63%	27 $9,000
Q4 2019 Jan 15, 2020	SELL	$220.06 - $304.07 $4,181 - $5,777	-19 Reduced 37.25%	32 $9,000
Q3 2019 Oct 15, 2019	BUY	$217.44 - $243.88 $11,089 - $12,437	51 New	51 $12,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of First Financial Corp , based on Form 13F filings with the SEC.

Stay updated on First Financial Corp with notifications on news.